In the realm of decision-making, Uri Maoz, a professor of computational neuroscience at Chapman University, is at the forefront of exploring how human desires and beliefs translate into actions. His journey into this complex field began in his twenties when an article prompted him to question the very nature of choice. Maoz’s reflections have since evolved into significant research efforts aimed at understanding the mechanisms behind decision-making processes. His work delves into the intricate factors that influence our choices, offering new insights into a long-standing debate in the field of cognitive science.
On another front, Moderna, the well-known manufacturer of COVID-19 vaccines, is pushing the boundaries of its mRNA technology by venturing into cancer treatment. The company is developing a groundbreaking approach that utilizes its mRNA platform to create personalized therapies aimed at tumor destruction. However, the terminology surrounding this innovation has led to controversy; while some, including representatives from Merck, are hesitant to label it as a vaccine, others argue it fits the definition. This rebranding effort appears to be a strategic move to mitigate public apprehension regarding vaccines, a sentiment that has grown in recent years. The ongoing discourse raises important questions about language and its impact on public perception of medical advancements.
These developments highlight the evolving landscape of technology and health, where understanding human behavior and innovative treatments intersect. As we continue to navigate these complexities, it becomes increasingly clear that the dialogue surrounding our choices, health technologies, and the implications of artificial intelligence will shape the future of our society.
Source: The Download: how humans make decisions, and Moderna’s “vaccine” word games via MIT Technology Review